Understanding EndoCare+, our purpose, institutional identity, and approach to specialized pharmaceutical activities in Yemen.
EndoCare+ is a specialized pharmaceutical platform operating in Yemen, with a focus on selected biopharmaceutical, endocrine, reproductive, metabolic, and specialty therapies.
The organization was established to support the responsible availability of specialized pharmaceutical products through a structured operating environment that brings together pharmaceutical knowledge, regulatory coordination, quality oversight, controlled supply, healthcare engagement, and pharmacovigilance.
Our work is centered on the responsible handling and continued availability of products that require specialized knowledge, controlled processes, and appropriate attention to patient safety.
Specialized therapeutic areas
Biopharmaceutical & hormonal focus
Documented quality & supply
Oversight & pharmacovigilance
EndoCare+ was developed around a clear need within the pharmaceutical environment in Yemen: specialized therapies require more than product distribution alone. They require appropriate regulatory coordination, controlled handling, informed healthcare engagement, quality oversight, and continuous attention to product safety.
The platform was therefore structured around these interconnected responsibilities, with a particular focus on therapeutic areas where product characteristics, storage requirements, regulatory considerations, and healthcare communication require specialized attention.
Today, EndoCare+ continues to develop its capabilities around this principle: supporting responsible access to specialized pharmaceutical therapies while maintaining appropriate quality, regulatory, operational, and safety practices.
A specialized pharmaceutical focus to address the need for responsible availability of complex therapies.
Building integrated pharmaceutical capabilities, connecting regulatory, quality, supply, and safety functions.
Supporting responsible access to specialty therapies in Yemen through a structured institutional platform.
Our identity is shaped by a set of principles that guide how we approach pharmaceutical products, healthcare relationships, and our responsibilities to patients and the wider healthcare environment.
We approach pharmaceutical activities with attention to product quality, regulatory requirements, patient safety, and responsible business practices.
We value accurate information, documented processes, accountability, and professional conduct across our activities.
We seek to maintain appropriate pharmaceutical knowledge, disciplined operations, and respectful engagement with healthcare stakeholders.
We work to support the responsible and sustained availability of specialized therapies through controlled and coordinated pharmaceutical activities.
To become a trusted specialized pharmaceutical platform supporting responsible access to specialty therapies in Yemen.
To support compliant pharmaceutical activities, controlled product supply, appropriate healthcare engagement, and patient-safety practices across our areas of focus.
EndoCare+ operates as a specialized pharmaceutical platform in Yemen with defined responsibilities across its activities. The platform operates in cooperation with Sabrah Pharma within the broader Sabrah pharmaceutical platform, benefiting from established pharmaceutical experience, healthcare-channel knowledge, operational resources, and broader institutional capabilities. This cooperation provides an institutional environment that supports EndoCare+'s activities while maintaining appropriate responsibility for its own specialized functions, regulatory requirements, quality processes, and operational activities.
We believe that specialized pharmaceutical activities require a coordinated approach rather than isolated functions. Our approach connects regulatory requirements with quality processes, controlled pharmaceutical operations, professional healthcare engagement, and patient-safety responsibilities. Each activity is approached according to its applicable requirements, documented procedures, risk considerations, and the nature of the products and stakeholders involved.
EndoCare+ is supported by professionals responsible for leadership, regulatory affairs, commercial activities, and pharmaceutical safety. Their roles reflect the functional responsibilities required to operate a specialized pharmaceutical platform.
Chief Executive Officer
Regulatory Affairs Manager
Marketing & Local Markets Manager
Pharmacovigilance Manager
Relevant corporate and regulatory documentation is maintained in accordance with applicable requirements and can be made available through appropriate formal channels where applicable.
Selected corporate, operational, quality, and regulatory documentation is available to qualified parties through appropriate formal channels, subject to applicable confidentiality and due-diligence requirements.
Learn more about our specialized areas, regulatory framework, quality practices, distribution capabilities, and patient-safety responsibilities.